Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae...

Related Keywords

China ,Italy ,United States ,Singapore ,Italian ,America ,Chong Zhao ,Christine Ann Miller ,Maurizio Luongo ,Menarini Asia Pacific ,Sciclone Pharmaceuticals Holdings Limited ,Sourcea Menarini Asia Pacific Holdings Pte ,World Health Organization ,China Antimicrobial Surveillance Network ,Sciclone Pharmaceuticals Holdings ,European Union ,Menarini Group ,Sciclone Pharmaceuticals ,Prnewswirea Menarini Asia Pacific Holdings Pte ,Melinta Therapeutics ,Menarini Asia Pacific Holdings ,Chief Executive Officer ,License Agreement ,Independent States ,Clone Pharmaceuticals ,Cidara Therapeutics ,Asia Pacific Holdings ,A Menarini Asia Pacific Holdings Pte Ltd ,